These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7678686

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST, Saksena S.
    Am J Cardiol; 1986 Apr 15; 57(11):941-6. PubMed ID: 3515898
    [Abstract] [Full Text] [Related]

  • 3. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF, MacNeil DJ, Zheutlin TA, Ezri MD, Nazari J, Spangenberg RB, Dunnington C, Lueken M.
    Am J Cardiol; 1993 Aug 12; 72(4):56A-66A. PubMed ID: 8346728
    [Abstract] [Full Text] [Related]

  • 5. Effects of intravenous cibenzoline on ventricular vulnerability and electrophysiology in patients with sustained ventricular tachycardia in comparison to a control group.
    Kühlkamp V, Schmid F, Mayer F, Ickrath O, Haasis R, Seipel L.
    J Cardiovasc Pharmacol; 1990 Mar 12; 15(3):472-5. PubMed ID: 1691372
    [Abstract] [Full Text] [Related]

  • 6. Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia. Cibenzoline and spontaneous VT.
    Chevalier P, Dacosta A, Chalvidan T, Bonnefoy E, Kirkorian G, Isaaz K, Touboul P.
    Int J Cardiol; 1998 May 15; 64(3):265-70. PubMed ID: 9672407
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W, Martinez-Rubio A, Hief C, Lammers A, Mühlenkamp S, Wichter T, Breithardt G, Borggrefe M.
    J Am Coll Cardiol; 1997 Aug 15; 30(2):487-95. PubMed ID: 9247523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].
    Hoffmann E, Bach P, Haberl R, Mattke S, Steinbeck G.
    Z Kardiol; 1992 Jul 15; 81(7):378-84. PubMed ID: 1509795
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M, Cappato R, Kuck KH.
    J Cardiovasc Pharmacol; 1995 Oct 15; 26(4):627-35. PubMed ID: 8569226
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF, Prystowsky EN, Zipes DP, Chilson DA, Heger JJ.
    J Am Coll Cardiol; 1984 Mar 15; 3(3):857-64. PubMed ID: 6693656
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V, Mermi J, Mewis C, Seipel L.
    J Cardiovasc Pharmacol; 1997 Mar 15; 29(3):373-81. PubMed ID: 9125676
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K, Feld G, Hendrickson J, Singh PN, Singh BN.
    Circulation; 1985 Sep 15; 72(3):555-64. PubMed ID: 4017207
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C, Kühlkamp V, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1989-95. PubMed ID: 10362204
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic effects of cibenzoline.
    Miura DS, Keren G, Torres V, Butler B, Aogaichi K, Somberg JC.
    Am Heart J; 1985 Apr 15; 109(4):827-33. PubMed ID: 3984837
    [Abstract] [Full Text] [Related]

  • 19. Sotalol: An important new antiarrhythmic.
    Anderson JL, Prystowsky EN.
    Am Heart J; 1999 Mar 15; 137(3):388-409. PubMed ID: 10047618
    [Abstract] [Full Text] [Related]

  • 20. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR, Gray RA, Karasik P, Moore HJ, Singh SN.
    Europace; 2014 Nov 15; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.